Structural conversion of neurotoxic amyloid-β1-42 oligomers to fibrils

被引:918
作者
Ahmed, Mahiuddin [1 ]
Davis, Judianne [2 ]
Aucoin, Darryl [1 ]
Sato, Takeshi [3 ]
Ahuja, Shivani [4 ]
Aimoto, Saburo [3 ]
Elliott, James I. [5 ]
Van Nostrand, William E. [2 ]
Smith, Steven O. [1 ]
机构
[1] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA
[2] SUNY Stony Brook, Dept Neurosurg & Med, Stony Brook, NY 11794 USA
[3] Osaka Univ, Inst Prot Res, Osaka, Japan
[4] SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA
[5] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA
基金
美国国家卫生研究院;
关键词
ASSISTED ROTATIONAL RESONANCE; BETA-AMYLOID FIBRILS; ALZHEIMERS-DISEASE; AGGREGATION PROPERTIES; PROTEIN; PEPTIDE; A-BETA-42; SHEET; NMR; PATHOGENESIS;
D O I
10.1038/nsmb.1799
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The amyloid-beta(1-42) (A beta 42) peptide rapidly aggregates to form oligomers, protofibils and fibrils en route to the deposition of amyloid plaques associated with Alzheimer's disease. We show that low-temperature and low-salt conditions can stabilize disc-shaped oligomers (pentamers) that are substantially more toxic to mouse cortical neurons than protofibrils and fibrils. We find that these neurotoxic oligomers do not have the beta-sheet structure characteristic of fibrils. Rather, the oligomers are composed of loosely aggregated strands whose C termini are protected from solvent exchange and which have a turn conformation, placing Phe19 in contact with Leu34. On the basis of NMR spectroscopy, we show that the structural conversion of A beta 42 oligomers to fibrils involves the association of these loosely aggregated strands into beta-sheets whose individual beta-strands polymerize in a parallel, in-register orientation and are staggered at an intermonomer contact between Gln15 and Gly37.
引用
收藏
页码:561 / U56
页数:8
相关论文
共 48 条
[31]  
Mayeux R, 1999, ANN NEUROL, V46, P412, DOI 10.1002/1531-8249(199909)46:3<412::AID-ANA19>3.0.CO
[32]  
2-A
[33]   Aβ42 is essential for parenchymal and vascular amyloid deposition in mice [J].
McGowan, E ;
Pickford, F ;
Kim, J ;
Onstead, L ;
Eriksen, J ;
Yu, C ;
Skipper, L ;
Murphy, MP ;
Beard, J ;
Das, P ;
Jansen, K ;
DeLucia, M ;
Lin, WL ;
Dolios, G ;
Wang, R ;
Eckman, CB ;
Dickson, DW ;
Hutton, M ;
Hardy, J ;
Golde, T .
NEURON, 2005, 47 (02) :191-199
[34]  
McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO
[35]  
2-M
[36]   The solvent protection of Alzheimer amyloid-β-(1-42) fibrils as determined by solution NMR spectroscopy [J].
Olofsson, A ;
Sauer-Eriksson, AE ;
Öhman, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (01) :477-483
[37]   Molecular structural basis for polymorphism in Alzheimer's β-amyloid fibrils [J].
Paravastu, Anant K. ;
Leapman, Richard D. ;
Yau, Wai-Ming ;
Tycko, Robert .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (47) :18349-18354
[38]   BETA-AMYLOID-(1-42) IS A MAJOR COMPONENT OF CEREBROVASCULAR AMYLOID DEPOSITS - IMPLICATIONS FOR THE PATHOLOGY OF ALZHEIMER-DISEASE [J].
ROHER, AE ;
LOWENSON, JD ;
CLARKE, S ;
WOODS, AS ;
COTTER, RJ ;
GOWING, E ;
BALL, MJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (22) :10836-10840
[39]   Inhibitors of amyloid toxicity based on β-sheet packing of Aβ40 and Aβ42 [J].
Sato, T ;
Kienlen-Campard, P ;
Ahmed, M ;
Liu, W ;
Li, HL ;
Elliott, JI ;
Aimoto, S ;
Constantinescu, SN ;
Octave, JN ;
Smith, SO .
BIOCHEMISTRY, 2006, 45 (17) :5503-5516
[40]   Aβ40-Lactam(D23/K28) models a conformation highly favorable for nucleation of amyloid [J].
Sciarretta, KL ;
Gordon, DJ ;
Petkova, AT ;
Tycko, R ;
Meredith, SC .
BIOCHEMISTRY, 2005, 44 (16) :6003-6014